Effects of 2,2,4,4-tetrabromodiphenyl ether on the development of mouse embryonic stem cells

Qiaoqiao Xu,Mingming Yu,Yuxia Zhou,Zhenyao Huang,Xiaomin Huang,Bo Xu,Kun Zhou,Xiaojiao Chen,Yankai Xia,Xinru Wang,Chuncheng Lu,Xiumei Han
DOI: https://doi.org/10.1016/j.reprotox.2021.09.008
IF: 3.421
2021-01-01
Reproductive Toxicology
Abstract:2,2',4,4'-Tetrabromodiphenyl ether (BDE47) poses potential risks to reproduction and development, but the mechanism of its toxicity has not yet been elucidated. To explore the developmental toxicity of BDE47, mouse embryonic stem cells (mESCs), which are ideal models for testing the developmental toxicity of environmental contaminants in vitro, were exposed to BDE47 (0.04 mu M, 1 mu M, 25 mu M, or 100 mu M) for 24 h or 48 h in this study. Our results indicated that BDE47 treatment changed the morphology of mESCs, inhibited cell viability and increased apoptosis. In addition, alkaline phosphatase (AP) staining in mESCs was significantly decreased after BDE47 treatment (25 mu M and 100 mu M), indicating that BDE47 treatment affected the pluripotency of mESCs. Through a cell immunofluorescence assay, we found that the fluorescence intensities of Oct4, Sox2 and Nanog were all significantly lower in the group treated with the highest BDE47 concentration (100 mu M) than in the control group, consistent with the qRT-PCR and Western blot results. The levels of miR-145 and miR-34a, which regulate genes related to cell differentiation, were significantly increased in BDE47-treated mESCs, further clarifying the potential mechanism. Overall, our findings demonstrate that BDE47 exposure upregulates the expression of miR-145 and miR-34a and in turn downregulates the expression of Oct4, Sox2 and Nanog, thereby affecting apoptosis and pluripotency and causing toxicity during embryonic development.
What problem does this paper attempt to address?